Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00103272
Status:
TERMINATED
Last Update Posted:
2013-06-04
First Post:
2005-02-07
Brief Title:
17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Waldenström Macroglobulinemia |
| Adult Acute Basophilic Leukemia |
| Adult Acute Eosinophilic Leukemia |
| Adult Acute Megakaryoblastic Leukemia M7 |
| Adult Acute Minimally Differentiated Myeloid Leukemia M0 |
| Adult Acute Monoblastic Leukemia M5a |
| Adult Acute Monocytic Leukemia M5b |
| Adult Acute Myeloblastic Leukemia With Maturation M2 |
| Adult Acute Myeloblastic Leukemia Without Maturation M1 |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Adult Acute Myelomonocytic Leukemia M4 |
| Adult Erythroleukemia M6a |
| Adult Pure Erythroid Leukemia M6b |
| Anaplastic Large Cell Lymphoma |
| Angioimmunoblastic T-cell Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Recurrent Adult Acute Lymphoblastic Leukemia |
| Recurrent Adult Acute Myeloid Leukemia |
| Recurrent Adult Diffuse Large Cell Lymphoma |
| Recurrent Adult T-cell LeukemiaLymphoma |
| Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Grade 3 Follicular Lymphoma |
| Recurrent Mantle Cell Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Recurrent Mycosis FungoidesSezary Syndrome |
| Recurrent Small Lymphocytic Lymphoma |
| Refractory Chronic Lymphocytic Leukemia |
| Small Intestine Lymphoma |
| Splenic Marginal Zone Lymphoma |
Keywords: